The digital health M&A wave is continuing, this time with Universal Health Services’ plan to acquire virtual behavioral health company Talkspace for $835 million. And it’s a deal that makes
Chronic Overmedication: The Polypharmacy Waste and Safety Problem
Polypharmacy rarely starts with a mistake. It starts with care. Nearly 42% of adults 65 and older are taking five or more prescription medications, and 12% are on ten or
Verily & Samsung Team Up to Bring Smartwatch Data into Clinical Trials
Verily and Samsung are teaming up to accelerate clinical research using wearable data, the companies announced Monday at the HIMSS conference in Las Vegas. The companies are integrating user data
Eight Sleep Raises $50M to Build Predictive AI for Sleep
Eight Sleep, a sleep technology company, announced last week that it raised $50 million in funding, which will help it transition into a predictive AI company for sleep. The New
Dialysis Isn’t Optional. Transportation Can’t Be Either
For non-emergency medical transportation (NEMT) companies, every patient on the daily schedule matters. Dialysis patients in particular depend on this service. Something as simple as moving from one place to another
It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?
In February, Congress finally took action to rein in PBMs via the Consolidated Appropriations Act of 2026. It included reforms like the delinking of PBM compensation from the price of
Roche, Zealand Pharma Obesity Drug Meets Clinical Trial’s Weight Loss Goals, But Can It Compete?
Obesity drug research is expanding to targets beyond GLP-1 with a goal of improving the side effect profile that leads many patients to stop treatment. A once-weekly injectable medication from
Future of Health Tech: From Structured Data to Scalable AI [Video]
Sellers Dorsey CTO Richard Queen talked about how advanced AI tech can be used to reduce operational pressures with Medicaid. He said it’s not the algorithms that have changed so
The Healthcare Industry Requires a New Kind of Leader
On any given day, healthcare leaders who would prefer to devote their time to improving patient care instead can find themselves overwhelmed with financial matters. At the same time, other
Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma
Servier is expanding its cancer drug prospects through the $2.5 billion acquisition of Day One Biopharmaceuticals, a biotech with a commercialized therapy for a type of pediatric glioma and clinical-stage







![Future of Health Tech: From Structured Data to Scalable AI [Video] Future of Health Tech: From Structured Data to Scalable AI [Video]](https://healthboostshop.com/wp-content/uploads/2026/03/Future-of-Health-Tech-From-Structured-Data-to-Scalable-AI.png)

